Eicosanoid signaling as a therapeutic target in middle-aged mice with severe COVID-19

Coronavirus disease 2019 (COVID-19) is especially severe in aged populations(1). Resolution of the COVID-19 pandemic has been advanced by the recent development of SARS-CoV-2 vaccines, but vaccine efficacy is partly compromised by the recent emergence of SARS-CoV-2 variants with enhanced transmissib...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Lok-Yin Roy, Zheng, Jian, Wilhelmsen, Kevin, Li, Kun, Ortiz, Miguel E., Schnicker, Nicholas J., Pezzulo, Alejandro A., Szachowicz, Peter J., Klumpp, Klaus, Aswad, Fred, Rebo, Justin, Narumiya, Shuh, Murakami, Makoto, Meyerholz, David K., Fortney, Kristen, McCray, Paul B., Perlman, Stanley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077574/
https://www.ncbi.nlm.nih.gov/pubmed/33907749
http://dx.doi.org/10.1101/2021.04.20.440676

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077574/
https://www.ncbi.nlm.nih.gov/pubmed/33907749
http://dx.doi.org/10.1101/2021.04.20.440676

Ejemplares similares